Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Tumor characteristics of dissociated response to immune checkpoint inhibition in advanced melanoma ; volume:73 ; number:2 ; day:27 ; month:1 ; year:2024 ; pages:1-10 ; date:2.2024
Cancer immunology immunotherapy ; 73, Heft 2 (27.1.2024), 1-10, 2.2024
- Classification
-
Medizin, Gesundheit
- Creator
-
Versluis, J. M.
Hoefsmit, E. P.
Shehwana, H.
Dimitriadis, P.
Sanders, J.
Broeks, A.
Blank, C. U.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-023-03581-6
- URN
-
urn:nbn:de:101:1-2404291311478.339652320004
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Versluis, J. M.
- Hoefsmit, E. P.
- Shehwana, H.
- Dimitriadis, P.
- Sanders, J.
- Broeks, A.
- Blank, C. U.
- SpringerLink (Online service)
Other Objects (12)
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer
Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
Tumour-informed liquid biopsies to monitor advanced melanoma patients under immune checkpoint inhibition
Predictors of responses to immune checkpoint blockade in advanced melanoma
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Neurosarcoidosis following Immune Checkpoint Inhibition
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
DNA methylation-based prediction of response to immune checkpoint inhibition in metastatic melanoma
Total serum N-glycans associate with response to immune checkpoint inhibition therapy and survival in patients with advanced melanoma
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
Checkpoint inhibition immunotherapy for advanced local and systemic conjunctival melanoma: a clinical case series
Cost-effectiveness of immune checkpoint inhibition and targeted treatment in combination as adjuvant treatment of patient with BRAF-mutant advanced melanoma
Evaluating immune checkpoint inhibition in colorectal cancer